2013
DOI: 10.1172/jci63672
|View full text |Cite
|
Sign up to set email alerts
|

Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression

Abstract: Concurrent activation of RAS/ERK and PI3K/AKT pathways is implicated in prostate cancer progression.The negative regulators of these pathways, including sprouty2 (SPRY2), protein phosphatase 2A (PP2A), and phosphatase and tensin homolog (PTEN), are commonly inactivated in prostate cancer. The molecular basis of cooperation between these genetic alterations is unknown. Here, we show that SPRY2 deficiency alone triggers activation of AKT and ERK, but this is insufficient to drive tumorigenesis. In addition to AK… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
91
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 81 publications
(99 citation statements)
references
References 42 publications
8
91
0
Order By: Relevance
“…Moreover, our results show that the positive staining signals of phosphorylated PTEN in CCA group were seen in the cytoplasm as well as in the nucleus of tumor cells. This may be due to the effect of phosphorylation of PTEN at Ser380/Threo382/ Threo383 which may promote nuclear accumulation (Patel et al, 2013). Moreover the expression of phosphorylated PTEN has been detected in many cancers, such as lung cancer (David, 2001), prostate cancer (Koumakpayi et al, 2010;Patel et al, 2013), and glioblastoma (Fenton et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, our results show that the positive staining signals of phosphorylated PTEN in CCA group were seen in the cytoplasm as well as in the nucleus of tumor cells. This may be due to the effect of phosphorylation of PTEN at Ser380/Threo382/ Threo383 which may promote nuclear accumulation (Patel et al, 2013). Moreover the expression of phosphorylated PTEN has been detected in many cancers, such as lung cancer (David, 2001), prostate cancer (Koumakpayi et al, 2010;Patel et al, 2013), and glioblastoma (Fenton et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…This may be due to the effect of phosphorylation of PTEN at Ser380/Threo382/ Threo383 which may promote nuclear accumulation (Patel et al, 2013). Moreover the expression of phosphorylated PTEN has been detected in many cancers, such as lung cancer (David, 2001), prostate cancer (Koumakpayi et al, 2010;Patel et al, 2013), and glioblastoma (Fenton et al, 2012). Therefore, our results suggest that PTEN inactivation by phosphorylation is responsible for PI3K/ AKT activation during CCA carcinogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…These data are in agreement with two recent reports showing that deletion of Spry family members in the context of Pten happloinsuficiency accelerates prostate tumorigenesis. 51,52 During the last years, it is becoming evident that OIS poses a potent barrier to tumoral transformation in vivo. Thus, the expression of activated Ras, E2f3 or B-Raf oncogenes in mice induces cellular senescence in premalignant tumors of the lung, pancreas, mammary gland, pituitary gland and melanoma.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have pointed out the significant role of sprouty2, a substrate of Mnk1, during multiple diseases or physiological process such as human mesenchymal stem cell differentiation, 17 papillary thyroid cancer, 18 and prostate cancer progression 19 by regulating ERK signaling pathway. ERK1/2 is one of the most important signaling that could provide new treatment strategies for cardiac hypertrophy and remodeling.…”
Section: Discussionmentioning
confidence: 99%